The N3RO trial: A randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks' gestation

C.T. Collins, R.A. Gibson, M. Makrides, A.J. Mcphee, T.R. Sullivan, P.G. Davis, M. Thio, Karen Simmer, V.S. Rajadurai, P. Ryan, S. Morris, M. Stark, J. Travadi, I. Wright, K. Tan, J. Holberton, G. Opie, I. Callander, J. Stack, D. SheinS. Bellhouse, S. Bolisetty, K. Lui, H. Liley, M. Berry, D. Harris, M.C. Chua, P. Agarwal

    Research output: Contribution to journalArticlepeer-review

    20 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The N3RO trial: A randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks' gestation'. Together they form a unique fingerprint.

    Medicine & Life Sciences